Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$30.95 USD
+1.11 (3.72%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $30.96 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Cassava Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 106 | 80 | 33 | 6 | 5 |
Income After Depreciation & Amortization | -106 | -80 | -33 | -6 | -5 |
Non-Operating Income | 9 | 4 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -97 | -76 | -32 | -6 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -97 | -76 | -32 | -6 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -97 | -76 | -32 | -6 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -104 | -79 | -32 | -6 | -5 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -106 | -80 | -33 | -6 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 41.93 | 40.20 | 39.41 | 26.11 | 17.41 |
Diluted EPS Before Non-Recurring Items | -2.32 | -1.90 | -0.82 | -0.24 | -0.27 |
Diluted Net EPS (GAAP) | -2.32 | -1.90 | -0.82 | -0.24 | -0.27 |
Fiscal Year end for Cassava Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 61.40 | 19.93 | 22.79 | 27.88 | 28.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | -61.40 | -19.93 | -22.79 | -27.88 | -28.78 |
Non-Operating Income | 67.56 | 44.98 | 1.87 | 2.23 | 2.40 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 6.16 | 25.04 | -20.92 | -25.65 | -26.38 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 6.16 | 25.04 | -20.92 | -25.65 | -26.38 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.16 | 25.04 | -20.92 | -25.65 | -26.38 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 46.20 | 44.10 | 42.19 | 42.00 | 41.79 |
Diluted EPS Before Non-Recurring Items | -1.28 | -1.41 | -0.50 | -0.61 | -0.63 |
Diluted Net EPS (GAAP) | 0.13 | -0.43 | -0.50 | -0.61 | -0.63 |